Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Desai, Aakash
Subbiah, Vivek
Dimou, Anastasios
Deshane, Jessy
Goliwas, Kayla
Ponnazhagan, Selvarangan
Das, Devika Govind
Khalil, Maya
Lo, Ying-Chun
Lin, Edwin H.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9037
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
    Bodor, J. Nicholas
    Boumber, Yanis
    Borghaei, Hossein
    CANCER, 2020, 126 (02) : 260 - 270
  • [2] Attribution of value for combination immune checkpoint inhibitors in non-small cell lung cancer
    Zaim, Remziye
    Redekop, Ken
    Uyl-de Groot, Carin A.
    JOURNAL OF CANCER POLICY, 2023, 35
  • [3] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC) Treatment: Quo Vadis?
    Gargalionis, Antonios N.
    Papavassiliou, Kostas A.
    Papavassiliou, Athanasios G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [4] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [5] Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
    Soria, Jean-Charles
    Marabelle, Aurelien
    Brahmer, Julie R.
    Gettinger, Scott
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2256 - 2262
  • [6] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [7] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [8] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [9] Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
    Yang, Jiali
    Chen, Juan
    Wei, Jun
    Liu, Xiaoming
    Cho, William C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1209 - 1223
  • [10] Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
    Jeanson, Arnaud
    Tomasini, Pascale
    Souquet-Bressand, Maxime
    Brandone, Nicolas
    Boucekine, Mohamed
    Grangeon, Mathieu
    Chaleat, Solene
    Khobta, Natalyia
    Milia, Julie
    Mhanna, Laurent
    Greillier, Laurent
    Biemar, Julie
    Nanni, Isabelle
    Ouafik, L'houcine
    Garcia, Stephane
    Mazieres, Julien
    Barlesi, Fabrice
    Mascaux, Celine
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : 1095 - 1101
12345